Clinical Cancer Advances 2008: Major Research Advances in Cancer Treatment, Prevention, and Screening—A Report From the American Society of Clinical Oncology
Eric P. Winer(Dana-Farber Cancer Institute), Richard L. Schilsky(Dana-Farber Brigham Cancer Center), Gregory Reaman(American Society of Clinical Oncology), Lisa Diller(Dana-Farber Cancer Institute), Patrick J. Loehrer(Indiana University School of Medicine), Julie R. Gralow(American Society of Clinical Oncology), George D. Demetri(American Society of Clinical Oncology), Lori J. Pierce(University of Pennsylvania), Mark G. Kris(American Society of Clinical Oncology), Howard M. Sandler(Cedars-Sinai Medical Center), Robert J. Mayer(CancerCare), Derek Raghavan(University of Southern California), Linda T. Vahdat(Dartmouth College), John Sweetenham(Cleveland Clinic), Beth Y. Karlan(University of Colorado Cancer Center), David Pfister(American Society of Clinical Oncology), Raymond Sawaya(American Society of Clinical Oncology), Patricia A. Ganz(University of California, Los Angeles), Barnett S. Kramer(American Society of Clinical Oncology), Maurie Markman(American Society of Clinical Oncology), Scott Ramsey(American Society of Clinical Oncology), Lynn M. Schuchter(Eastern Cooperative Oncology Group)
Cited by 290
Related Papers
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial
|Journal of Clinical Oncology|2015|2.6k
Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer
|New England Journal of Medicine|2003|2.6k
Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment
|JAMA|2017|2.3k
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k